Dr. Schweizer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2011 - 2014
University of ChicagoResidency, Internal Medicine, 2008 - 2011
Lewis Katz School of Medicine at Temple UniversityClass of 2008
Certifications & Licensure
WA State Medical License 2014 - 2025
AK State Medical License 2022 - 2024
MD State Medical License 2011 - 2015
IL State Medical License 2008 - 2011- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer Start of enrollment: 2020 Apr 27
- A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer Start of enrollment: 2020 Feb 06
- A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2019 Nov 22
- Join now to see all
Publications & Presentations
PubMed
- Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.Joseph J Park, Alec Chu, Jinju Li, Alicia Ali, Rana R McKay, Clara Hwang, Matthew K Labriola, Albert Jang, Deepak Kilari, George Mo, Deepak Ravindranathan, Laura S Gra...> ;JCO Precision Oncology. 2024 Apr 1
- ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATES.Ajkunic, A., Sayar, E., Roudier, M., Patel, R., Coleman, I., De Sarkar, N., Hanratty, B., Adil, M., Zhao, J., Zaidi, S., True, L., Sperger, J., Cheng, H., Yu, E., Mont...> ;Research Square. 2023 Dec 19
- Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.Orme, J., Taza, F., De Sarkar, N., Tewari, A., Arsalan Naqvi, S., Riaz, I., Childs, D., Omar, N., Adra, N., Ashkar, R., Cheng, H., Schweizer, M., Sokolova, A., Agarwal...> ;European Urology Oncology. 2023 Dec 9
- Join now to see all
Journal Articles
- Association of Clonal Hematopoiesis in DNA Repair Genes with Prostate Cancer Plasma Cell-Free DNA Testing InterferenceMichael T Schweizer, Petros Grivas, Heather H Cheng, Evan Y Yu, JAMA Oncology
Press Mentions
Madison Vaccines Incorporated Expands Clinical Trial of MVI-118 for Prostate Cancer to University of WashingtonMarch 21st, 2017
Bipolar Androgen Therapy Promising for Advanced HormoneSensitive PCaJanuary 5th, 2016- Bipolar Androgen Therapy May Benefit Men with Prostate CancerJanuary 9th, 2015
- Join now to see all
Hospital Affiliations
Fred Hutchinson Cancer CenterSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
